2-Acetyl-6-methoxynaphthaleneCAS# 3900-45-6 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 3900-45-6 | SDF | Download SDF |
PubChem ID | 77506 | Appearance | Powder |
Formula | C13H12O2 | M.Wt | 200 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | 1-(6-methoxynaphthalen-2-yl)ethanone | ||
SMILES | CC(=O)C1=CC2=C(C=C1)C=C(C=C2)OC | ||
Standard InChIKey | GGWCZBGAIGGTDA-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C13H12O2/c1-9(14)10-3-4-12-8-13(15-2)6-5-11(12)7-10/h3-8H,1-2H3 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
2-Acetyl-6-methoxynaphthalene Dilution Calculator
2-Acetyl-6-methoxynaphthalene Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 5 mL | 25 mL | 50 mL | 100 mL | 125 mL |
5 mM | 1 mL | 5 mL | 10 mL | 20 mL | 25 mL |
10 mM | 0.5 mL | 2.5 mL | 5 mL | 10 mL | 12.5 mL |
50 mM | 0.1 mL | 0.5 mL | 1 mL | 2 mL | 2.5 mL |
100 mM | 0.05 mL | 0.25 mL | 0.5 mL | 1 mL | 1.25 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Gelsevirine
Catalog No.:BCN5443
CAS No.:38990-03-3
- (S)-CPW 399
Catalog No.:BCC7106
CAS No.:389888-02-2
- α-Tocopherol phosphate
Catalog No.:BCC5420
CAS No.:38976-17-9
- Ophiopogonin B
Catalog No.:BCN5378
CAS No.:38971-41-4
- 2'-O-Methylperlatolic acid
Catalog No.:BCN5442
CAS No.:38968-07-9
- Eriodictyol-7-O-glucoside
Catalog No.:BCN4743
CAS No.:38965-51-4
- N-Acetylnorloline
Catalog No.:BCN2005
CAS No.:38964-35-1
- Raspberry ketone glucoside
Catalog No.:BCC8244
CAS No.:38963-94-9
- Prasugrel Maleic acid
Catalog No.:BCC4292
CAS No.:389574-20-3
- Prasugrel hydrochloride
Catalog No.:BCC4291
CAS No.:389574-19-0
- Piperlotine A
Catalog No.:BCN6481
CAS No.:389572-70-7
- Icariside D2
Catalog No.:BCN7217
CAS No.:38954-02-8
- Albiflorin
Catalog No.:BCN1264
CAS No.:39011-90-0
- Oxypaeoniflorin
Catalog No.:BCN6346
CAS No.:39011-91-1
- Nuezhenide
Catalog No.:BCN5444
CAS No.:39011-92-2
- Iristectorigenin A
Catalog No.:BCN8393
CAS No.:86849-77-6
- Epimedoside A
Catalog No.:BCN2886
CAS No.:39012-04-9
- Picroside II
Catalog No.:BCN6323
CAS No.:39012-20-9
- (E)-2-(3-(3,4-dimethoxyphenyl)acryloyloxy)succinic acid
Catalog No.:BCN8545
CAS No.:39015-77-5
- Wilsonine
Catalog No.:BCN5445
CAS No.:39024-12-9
- 3-Epiwilsonine
Catalog No.:BCN5446
CAS No.:39024-15-2
- Z-Guggulsterone
Catalog No.:BCC7712
CAS No.:39025-23-5
- Guggulsterone E
Catalog No.:BCC8181
CAS No.:39025-24-6
- 9-Methoxycamptothecine
Catalog No.:BCN1219
CAS No.:39026-92-1
Effective anodic oxidation of naproxen by platinum nanoparticles coated FTO glass.[Pubmed:24656855]
J Hazard Mater. 2014 Jul 30;277:110-9.
This study investigated applications of the electrochemical anodic oxidation process with Pt-FTO and Pt/MWCNTs-FTO glasses as anodes on the treatment of one of the most important emerging contaminants, naproxen. The anodes used in this study have been synthesized using commercial FTO, MWCNTs and Pt nanoparticles (PtNP). XRD patterns of Pt nanoparticles coated on FTO and MWCNTs revealed that MWCNTs can prevent the surface of PtNPs from sintering and thus provide a greater reaction sites density to interact with naproxen, which have also been confirmed by higher degradation and mineralization efficiencies in the Pt/MWCNTs-FTO system. Results from the CV analysis showed that the Pt-FTO and Pt/MWCNTs-FTO electrodes possessed dual functions of decreasing activation energy and interactions between hydroxyl radicals to effectively degrade naproxen. The lower the solution pH value, the better the degradation efficiency. The existence of humic acid indeed inhibited the degradation ability of naproxen due to the competitions in the multiple-component system. The electrochemical degradation processes were controlled by diffusion mechanism and two major intermediates of 2-Acetyl-6-methoxynaphthalene and 2-(6-Hydroxy-2-naphthyl)propanoic acid were identified. This study has successfully demonstrated new, easy, flexible and effective anodic materials which can be feasibly applied to the electrochemical oxidation of naproxen.